Rafael Renatino Canevarolo

14PUBLICATIONS
123CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyInter-organisational, extra-organisational and global information systemsCancer diagnosisMedical mycology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Oct 01, 2026
Venetoclax-based Therapy Improves Outcomes across the Evolving Biology of t(11;14) Multiple Myeloma.

|Aug 20, 2026
Fluctuating environment causes neoplastic transition and epithelial-mesenchymal plasticity in human cells.

|Jun 12, 2026
The Oncology Research Information Exchange Network (ORIEN) - Building a Real-World Collaborative, Patient-driven Infrastructure for Discovery Research and Precision Oncology.

|Jun 03, 2026
Integrated Genomic and Epigenomic Analysis Reveals Epigenetic Plasticity in Disease Progression and Multidrug Resistance in Multiple Myeloma.

|Oct 08, 2025
Genomics Define Malignant Transformation in Myeloma Precursor Conditions.

Francesco Maura, P Leif Bergsagel, Bachisio Ziccheddu

|Sep 22, 2025
Target antigen and plasma cell phenotype are critical factors for sensitivity to response-adapted daratumumab therapy.

Mark B Meads, Xiaohong Zhao, David Noyes

Pageof 3

Frequent Collaborators

12 joint publications

Praneeth Sudalagunta

8 joint publications

Ariosto Siqueira Silva

5 joint publications

Kenneth H Shain

5 joint publications

Rachid C Baz